DNLI
#1523
Denali Therapeutics Inc. - Common Stock
24.6 7 USD
0.00%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+0.41%
Changement Mensuel
+3.31%
Evolution sur 6 mois
+17.28%
Changement Annuel
+52.57%
Clôture Précédente
24.5 7
Open
24.6 7
Low
24.6 7
High
24.6 7
Volume
112
Financials
- Market Capitalization 3.94 B
- Employee 507
- Founded 2013
- CEO N/A
- Website www.denalitherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG008P7F869
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-5.56
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1511 |  IDYA IDEAYA Biosciences, Inc. - Common Stock | 41.77 USD | +0.46% | +6.18% | +15.67% | +28.21% | 4.03 B USD | ||
| 1522 |  VKTX Viking Therapeutics, Inc. - Common Stock | 33.86 USD | -1.51% | -2.67% | +0.03% | +22.42% | 3.95 B USD | ||
| 1533 |  RCUS Arcus Biosciences, Inc. Common Stock | 30.60 USD | -0.55% | +2.14% | +11.31% | +186.79% | 3.90 B USD | ||
| 1545 |  TLX Telix Pharmaceuticals Limited - American Depositary Shares | 11.38 USD | +2.25% | +0.35% | +10.70% | +80.35% | 3.86 B USD |